Middle Market Weekly Outlook

With Pfizer and Allergan poised for a merger, Forbes ponders whether we should we change the tax code to prevent corporate inversions. Meanwhile, the New York Times asks: Did Pfizer even need an inversion to avoid taxes? Plus, Pfizer assures the public that its execs will pay capital gains taxes.

Insights

• “No holiday cheer for investors this year.”
• Will CalPERS’ disclosure lead to more transparency in private equity?
• Buyout firms are sitting out
• PE is looking for bargains in Nigeria
• Profitable sales drive up compensation for investors
• When it comes to the markets, stability can lead to fragility

Transactions

• Peak Rock Capital acquires Berner Food and Beverage
• Alothon Group invests in Grupo MPR
• Calverton Holdings acquires Kerkhoff Associates Inc.
• Dynojet Research Inc. acquired by Irving Place Capital and New Value Capital
• Kinderhook Industries acquires Sumter Transport Co.
• QualaWash Holdings acquires Gator Environmental & Rentals Inc.
• Wellspring Capital Management acquires AdvoServ
• Forefront Dermatology acquires Premier Dermatology

This Week in History… President Theodore Roosevelt goes in front of the House of Representatives in support of antitrust laws “within reasonable limits.” Roosevelt is remembered for his fights against big business, though in fact he took relatively moderate positions to curb so-called robber barons and protect what he saw as the interests of the American people. (1901)